Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,771 | 240 | 99.6% |
| Education | $21.03 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $816.13 | 43 | $0 (2024) |
| Relypsa, Inc. | $511.26 | 30 | $0 (2020) |
| Amgen Inc. | $426.96 | 18 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $275.17 | 13 | $0 (2023) |
| Vifor Pharma, Inc. | $237.78 | 15 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $190.73 | 11 | $0 (2019) |
| PFIZER INC. | $184.89 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $182.06 | 6 | $0 (2024) |
| Travere Therapeutics, Inc. | $168.28 | 7 | $0 (2024) |
| Lilly USA, LLC | $163.76 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $662.14 | 28 | Boehringer Ingelheim Pharmaceuticals, Inc. ($150.29) |
| 2023 | $710.39 | 32 | AstraZeneca Pharmaceuticals LP ($158.57) |
| 2022 | $304.77 | 14 | AstraZeneca Pharmaceuticals LP ($67.78) |
| 2021 | $648.39 | 36 | AstraZeneca Pharmaceuticals LP ($328.78) |
| 2020 | $341.46 | 17 | Relypsa, Inc. ($108.53) |
| 2019 | $1,012 | 55 | Relypsa, Inc. ($210.20) |
| 2018 | $533.97 | 30 | Relypsa, Inc. ($110.80) |
| 2017 | $579.44 | 29 | BAXTER HEALTHCARE ($95.08) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.14 | General |
| 11/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $25.04 | General |
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Nephrology | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.85 | General |
| 08/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Inflammation | ||||||
| 07/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Nephrology | ||||||
| 07/19/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Nephrology | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: DIABETES | ||||||
| 03/08/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 855 | 1,770 | $450,395 | $194,982 |
| 2022 | 16 | 1,133 | 2,228 | $619,680 | $293,642 |
| 2021 | 19 | 1,236 | 2,601 | $770,545 | $364,318 |
| 2020 | 19 | 1,280 | 11,453 | $872,815 | $339,972 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 54 | 258 | $167,700 | $81,234 | 48.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 50 | 160 | $88,000 | $41,548 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 262 | $65,500 | $17,554 | 26.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 80 | 80 | $24,000 | $10,876 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 138 | $23,460 | $7,860 | 33.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 175 | $15,750 | $6,855 | 43.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 61 | $14,640 | $6,626 | 45.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 16 | 24 | $10,320 | $4,404 | 42.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 27 | $12,690 | $4,272 | 33.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 52 | $8,580 | $3,757 | 43.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 185 | 399 | $3,990 | $3,318 | 83.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $8,580 | $2,847 | 33.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 33 | $4,125 | $2,502 | 60.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $1,380 | $827.54 | 60.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 55 | 56 | $1,680 | $502.63 | 29.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 115 | 391 | $215,050 | $108,164 | 50.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 76 | 171 | $111,150 | $56,808 | 51.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 88 | 179 | $76,970 | $34,057 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 250 | $62,500 | $26,330 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 177 | $30,090 | $12,381 | 41.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $19,800 | $10,126 | 51.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 104 | $24,960 | $9,904 | 39.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 126 | $20,790 | $8,359 | 40.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 28 | 144 | $12,960 | $7,975 | 61.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $13,630 | $5,236 | 38.4% |
About Dr. Alan Friedman, MD
Dr. Alan Friedman, MD is a Nephrology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598867285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Friedman, MD has received a total of $4,792 in payments from pharmaceutical and medical device companies, with $662.14 received in 2024. These payments were reported across 241 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,771).
As a Medicare-enrolled provider, Friedman has provided services to 4,504 Medicare beneficiaries, totaling 18,052 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Bronx, NY
- Active Since 09/02/2006
- Last Updated 01/11/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1598867285
Products in Payments
- Veltassa (Drug) $749.04
- LOKELMA (Drug) $580.02
- FARXIGA (Drug) $218.09
- Parsabiv (Drug) $196.51
- AURYXIA (Drug) $192.98
- JANUVIA (Drug) $190.73
- JARDIANCE (Drug) $176.17
- Auryxia (Drug) $174.57
- JYNARQUE (Drug) $149.19
- KRYSTEXXA (Biological) $129.36
- Parsabiv (Biological) $118.02
- TAVNEOS (Drug) $112.43
- TRULICITY (Drug) $103.18
- Renal - Non Product Related (Biological) $95.08
- Kerendia (Drug) $84.43
- Velphoro (Drug) $79.69
- LUPKYNIS (Drug) $78.23
- PREVNAR - 13 (Biological) $74.77
- TARPEYO (Drug) $71.39
- IBSRELA (Drug) $67.35
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Bronx
Dr. Bruce Spinowitz, M.d, M.D
Nephrology — Payments: $510,667
Joel Neugarten, Md, MD
Nephrology — Payments: $384,806
Enver Akalin, M.d, M.D
Nephrology — Payments: $76,364
John He, Md, MD
Nephrology — Payments: $24,885
Abdurhman Ahmed, M.d, M.D
Nephrology — Payments: $12,466
Dr. Suman Reddy, Md, MD
Nephrology — Payments: $7,783